TABLE 2.
Body System | N = 49 |
---|---|
% (n) | |
Gastrointestinal | |
Diarrhea | 44.9% (22) |
Rectal Bleeding | 16.3% (8) |
Abdominal Painc, d | 26.5 (13) |
Nausea | 10.2% (5) |
Vomiting | 6.1% (3) |
Heart Burn | 4.1% (2) |
Constipation | 2% (1) |
Rectal Abscess | 2% (1) |
Right lower Quadrant Pain | 2% (1) |
Gastritis | 2% (1) |
Bloating | 2% (1) |
Discoloured Stool | 2% (1) |
IBD flarea | 2% (1) |
Systemic | |
Fever | 10.2% (5) |
Fatigue | 6.1% (3) |
Chills | 4.1% (2) |
Night sweats | 2% (1) |
Anemiab | 2% (1) |
Burning pain on feet | 2% (1) |
Pedal bilateral edema | 2% (1) |
Respiratory | |
Cough | 2% (1) |
Dermatologic | |
Shingles | 2% (1) |
Eczema | 2% (1) |
Cyst | 2% (1) |
Swollen lymph nodes | 2% (1) |
Rash | 2% (1) |
Polymorphous light eruption | 2% (1) |
Skin abscess | 2% (1) |
Neurological | |
Migraine | 4.1% (2) |
Genitourinary | |
Yeast infection | 4.1% (2) |
Kidney stones | 2% (1) |
Musculoskeletal | |
Muscle soreness | 2% (1) |
Back pain | 2% (1) |
Infection | |
Oral infection | 2% (1) |
Pharyngitis | 2% (1) |
aGrade 3 IBD flare that resulted in a hospitalization in 1 subject reported during the week 8 follow-up. Subject was treated with Remicade and discharged from hospital.
bSubject with anemia required blood transfusions and reported the event during their week 8 follow-up. The event was deemed to be disease-related not treatment-related; it was resolved with transfusion.
cSubject went to ER for general GI pain and reported the event during their week 26 follow-up. Subject was given Percocet to take as needed.
dOne subject visited the ER due to abdominal pain and reported this event during their week-12 visit. Subject was treated with pain medication.